Birkett D J, Kapitulnik J
Clin Chim Acta. 1976 Sep 6;71(2):129-35. doi: 10.1016/0009-8981(76)90522-2.
Iophenoxic acid increases the fluorescence of bilirubin bound to human serum albumin at drug/albumin molar ratios lower than 1, while iopanoic acid decreases it. The fluorescence enhancement results probably from a change in the fluorescence efficiency due to an iophenoxic acid-induced conformational change in the albumin, which in turn causes displacement of bilirubin from the protein. Iophenoxic acid does not affect the high-affinity bilirubin binding site of albumin. Therefore any enhancement in bilirubin fluorescence caused by the drug indicates that bilirubin is bound to the low-affinity binding sites of albumin. The use of iophenoxic acid in the determination of the extent of saturation of the high-affinity bilirubin binding site of albumin may be of value in the clinical management of infants with neonatal jaundice.
在药物/白蛋白摩尔比低于1时,碘苯氧酸会增加与人类血清白蛋白结合的胆红素的荧光,而碘番酸则会降低其荧光。荧光增强可能是由于碘苯氧酸诱导白蛋白构象变化导致荧光效率改变,进而使胆红素从蛋白质上解离。碘苯氧酸不影响白蛋白的高亲和力胆红素结合位点。因此,该药物引起的胆红素荧光增强表明胆红素与白蛋白的低亲和力结合位点结合。在新生儿黄疸婴儿的临床管理中,使用碘苯氧酸测定白蛋白高亲和力胆红素结合位点的饱和程度可能具有重要价值。